SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932440-14-000102
Filing Date
2014-02-14
Accepted
2014-02-14 16:10:35
Documents
1
Group Members
RIDGEBACK CAPITAL INVESTMENTS LTD.RIDGEBACK CAPITAL MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sc13ga_2216945.htm SC 13G/A 153889
  Complete submission text file 0000932440-14-000102.txt   155467
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE NEW YORK NY 10022 212-831-1111
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87209 | Film No.: 14616524
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011
Business Address 75 NINTH AVENUE 5TH FLOOR NEW YORK NY 10011 212-624-2567
Ridgeback Capital Investments L.P. (Filed by) CIK: 0001423994 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A